Methyldopa and Hypoglycemia - a phase IV clinical study of FDA data

Summary:

Hypoglycemia is reported as a side effect among people who take Methyldopa (methyldopa), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Diabetes.

The phase IV clinical study analyzes which people have Hypoglycemia when taking Methyldopa. It is created by eHealthMe based on reports of 6,345 people who have side effects when taking Methyldopa from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Hypoglycemia?

Hypoglycemia (low blood sugar) is found to be associated with 1,706 drugs and 2,377 conditions by eHealthMe. Check the latest studies of Hypoglycemia.

On Jul, 18, 2026

6,345 people reported to have side effects when taking Methyldopa.
Among them, 36 people (0.57%) have Hypoglycemia.

Among these 36 people:

How long have people been on Methyldopa when they have Hypoglycemia? *

What is the gender of people who have Hypoglycemia when taking Methyldopa? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Hypoglycemia when taking Methyldopa? *

What are other drugs people take besides Methyldopa? *

What are other side effects people have besides Hypoglycemia? *

Arrhythmias (irregular heartbeat): 6 people, 16.67%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 6 people, 16.67%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 6 people, 16.67%
Hypotension (abnormally low blood pressure): 5 people, 13.89%
Agitation (state of anxiety or nervous excitement): 5 people, 13.89%
Hyperbilirubinaemia (excess of bilirubin in the blood): 4 people, 11.11%
Low Birth Weight Baby: 4 people, 11.11%
Blood Glucose Abnormal: 4 people, 11.11%
Hepatic Enzyme Increased: 4 people, 11.11%
Nausea (feeling of having an urge to vomit): 4 people, 11.11%

What are the existing conditions these people have? *

Diabetes: 4 people, 11.11%
Depression: 3 people, 8.33%
Zinc Deficiency: 2 people, 5.56%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 5.56%
Cardiac Failure: 2 people, 5.56%
Constipation: 2 people, 5.56%
Delirium (wild excitement): 2 people, 5.56%
Type 2 Diabetes: 2 people, 5.56%
Hiv Infection: 2 people, 5.56%
Gestational Diabetes (diabetes in pregnancy): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and have Hypoglycemia?

- Check whether Hypoglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methyldopa:

Methyldopa (6,475 reports)

Hypoglycemia treatments and more:

Hypoglycemia (57,734 reports)

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoglycemia:

Hypoglycemia (1,706 drugs)

Browse all the conditions that are associated with Hypoglycemia:

Hypoglycemia (2,377 conditions)

Related publications that referenced our studies

Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Methyldopa) and Methyldopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.